<DOC>
	<DOCNO>NCT02076672</DOCNO>
	<brief_summary>This single-arm phase II trial ass biological activity ( sub-cohort use Simon two-stage Phase II design ) toxicity Artichoke Whole Phytocomplex Concentrate ( WPC ) . The objective study explore potential non-toxic phytocomplex extract artichoke plant chemoprevention agent .</brief_summary>
	<brief_title>Investigation Anti-Cancer Activity Artichoke Extract Asbestos-Exposed Population</brief_title>
	<detailed_description>In individual expose asbestos affected asbestosis asbestos-related benign pleural disease , therefore increase risk mesothelioma , investigator evaluate whether treatment commercially-available Artichoke Whole Phytocomplex Concentrate ( Artichoke WPC ) 90 day decrease mesothelin serum level . Although investigator general information toxicity human , investigator monitor assess potential toxicity Artichoke WPC patient population . In addition mesothelin , investigator plan evaluate effect Artichoke WPC serum microRNAs ( miRNAs ) . The use miRNAs minimally-invasive biomarkers open new opportunity diagnosis cancer . A number study address potential association disregulated miRNA profile benign asbestos-related disease mesothelioma . Thus , investigator evaluate serum miRNA profile treatment Artichoke WPC .</detailed_description>
	<criteria>1 . Asbestosis ( define diffuse lung scar base increased profusion interstitial fibrosis ) 2 . Benign pleural disease ( define thicken fibrotic plaque pleural surface lung bilaterally ) 1 . Prior systemic chemotherapy , radiation therapy . 2 . A current previous history primary malignancy . 3 . Known allergy artichoke . 4 . Known bile duct obstruction . 5 . Known pregnancy lactate woman . 6 . Known psychiatric illness/social situation would limit study compliance . 7 . Receiving investigational agent . 8 . Inability understand unable provide write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>prevention</keyword>
	<keyword>non-malignant asbestos-related disease</keyword>
	<keyword>benign pleural disease</keyword>
	<keyword>asbestosis</keyword>
</DOC>